N-docosanoylsphingosine-1-phosphocholine

Metabolite details

Identifier

FJJANLYCZUNFSE-TWKUQIQBSA-N

InChI Key

FJJANLYCZUNFSE-TWKUQIQBSA-N

IUPAC name

(2S,3R,4E)-2-(docosanoylamino)-3-hydroxyoctadec-4-en-1-yl 2-(trimethylazaniumyl)ethyl phosphate

Preferred name

N-docosanoylsphingosine-1-phosphocholine

INN name

—

Synonym

N-(docosanoyl)-sphing-4-enine-1-phosphocholine

ChEBI

CHEBI:74532

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Metabolomic Profile of Diet-Induced Obesity Mice in Response to Human and Small Humanin-like Peptide 2 Treatment
• Global analysis of plasma lipidomics reveals altered lipid signatures in patients with osteonecrosis of the femoral head
• Transcriptional differentiation of Trypanosoma brucei during in vitro acquisition of resistance to acoziborole
• Metabolic characterization of the natural progression of chronic hepatitis B (Lipid assays).
• Sexual dimorphism in the fetal cardiac response to maternal nutrient restriction.
• PKM2 methylation by CARM1 activates aerobic glycolysis to promote tumorigenesis.
• Transcript variants of long-chain acyl-CoA synthase 1 have distinct roles in sheep lipid metabolism
• Transcriptomic and lipidomic profiling of subcutaneous and visceral adipose tissues in 15 vertebrates
• Metabolic changes associated with tick-microbe interactions
• Integrated multi-omics analysis of adverse cardiac remodeling and metabolic inflexibility upon ErbB2 and ERRα deficiency.

Observed in differential profiles

• Water_vs_HNG
• Water_vs_HNG
• Water_vs_HNG
• Water_vs_HNG
• Control_vs_AONFH_Stage_III_IV
• WT_vs_WT_Aco
• Control_vs_Immune_Tolerant
• Control_vs_Immune_Tolerant
• Control_vs_Immune_Tolerant
• Control_Female_vs_Restricted_Female
• Control_Female_vs_Restricted_Female
• MCF-7_WT_vs_MCF-7_PKM2_KO
• Knockdown_vs_Control
• Knockdown_vs_Control
• G1_Sheep_ASA_SAT_vs_G2_Sheep_GOM_VAT
• Uninfected_1h_vs_Anaplasma_phagocytophilum_1h
• WT_vs_ErbB2_KI